Aline Houessinon

737 total citations
10 papers, 420 citations indexed

About

Aline Houessinon is a scholar working on Oncology, Epidemiology and Cell Biology. According to data from OpenAlex, Aline Houessinon has authored 10 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Epidemiology and 3 papers in Cell Biology. Recurrent topics in Aline Houessinon's work include Endoplasmic Reticulum Stress and Disease (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Aline Houessinon is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Aline Houessinon collaborates with scholars based in France, Switzerland and Japan. Aline Houessinon's co-authors include Bruno Chauffert, Antoine Galmiche, Chloé Sauzay, Jean‐Claude Barbare, Zuzana Saidak, Christophe Louandre, Corinne Godin, Sandra Bodeau, Romain Coriat and Laurent Gutierrez and has published in prestigious journals such as Molecular Cancer, Cancer Letters and Clinica Chimica Acta.

In The Last Decade

Aline Houessinon

9 papers receiving 416 citations

Peers

Aline Houessinon

MB

CR

PRM

ONCOL

HEPAT

Mincheng Yu China

Siyu Tan China

Yuqiang Shan China

Yusuke Wada Japan

Tian Lan China

Qi Song China

Jiuliang Yan China

Lan Wei United States

Anrong Mao China

Jianghua Ran China

Mincheng Yu China

Aline Houessinon

232 ×1.2

MB

160 ×1.1

CR

89 ×0.6

PRM

130 ×1.3

ONCOL

23 ×0.3

HEPAT

Citations per year, relative to Aline Houessinon Aline Houessinon (= 1×) peers Mincheng Yu

Countries citing papers authored by Aline Houessinon

Since Specialization

Citations

This map shows the geographic impact of Aline Houessinon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aline Houessinon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aline Houessinon more than expected).

Fields of papers citing papers by Aline Houessinon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aline Houessinon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aline Houessinon. The network helps show where Aline Houessinon may publish in the future.

Co-authorship network of co-authors of Aline Houessinon

This figure shows the co-authorship network connecting the top 25 collaborators of Aline Houessinon. A scholar is included among the top collaborators of Aline Houessinon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aline Houessinon. Aline Houessinon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Houessinon, Aline, et al.. (2025). Defining end-of-life in glioblastoma multiforme: a systematic review. Journal of Neuro-Oncology. 174(1). 53–63.

2.

Even, Caroline, et al.. (2024). Management of oligometastatic head and neck squamous cell carcinoma: A systematic review. Oral Oncology. 159. 107085–107085. 4 indexed citations

3.

Chaby, G., Sophie Liabeuf, Valérie Gras‐Champel, et al.. (2021). Associations between dysbiosis-inducing drugs, overall survival and tumor response in patients treated with immune checkpoint inhibitors. Therapeutic Advances in Medical Oncology. 13. 4277412623–4277412623. 36 indexed citations

4.

Houessinon, Aline, J. Bettoni, Chloé Sauzay, et al.. (2020). Resensitization to Nivolumab after Intratumoral Chemotherapy in Recurrent Head and Neck Squamous Cell Cancer: A Report of 2 Cases. Case Reports in Oncology. 13(2). 835–842. 1 indexed citations

5.

Saidak, Zuzana, Denis Chatelain, Chloé Sauzay, et al.. (2018). Squamous Cell Carcinoma Antigen-encoding Genes SERPINB3/B4 as Potentially Useful Markers for the Stratification of HNSCC Tumours. Anticancer Research. 38(3). 1343–1352. 12 indexed citations

6.

Galmiche, Antoine, Chloé Sauzay, Aline Houessinon, Bruno Chauffert, & Olivier Pluquet. (2016). Probing Tumour Proteostasis and the UPR with Serum Markers. Trends in cancer. 2(5). 219–221. 5 indexed citations

7.

Houessinon, Aline, Chloé Sauzay, Christophe Louandre, et al.. (2016). Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib. Molecular Cancer. 15(1). 38–38. 116 indexed citations

8.

Sauzay, Chloé, et al.. (2016). Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma. Clinica Chimica Acta. 463. 39–44. 210 indexed citations

9.

Houessinon, Aline, Christophe Louandre, Rémy Nyga, et al.. (2015). Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenib. Cancer Letters. 370(2). 242–249. 22 indexed citations

10.

Houessinon, Aline, Mathieu Boone, Jean‐Marc Constans, P. Toussaint, & Bruno Chauffert. (2015). Sustained Response of a Clivus Chordoma to Erlotinib after Imatinib Failure. Case Reports in Oncology. 8(1). 25–29. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact